These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 35890211)

  • 41. Evolution of strategies to improve preclinical cardiac safety testing.
    Gintant G; Sager PT; Stockbridge N
    Nat Rev Drug Discov; 2016 Jul; 15(7):457-71. PubMed ID: 26893184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multi-labeled neural network model for automatically processing cardiomyocyte mechanical beating signals in drug assessment.
    Ouyang Q; Yang W; Wu Y; Xu Z; Hu Y; Hu N; Zhang D
    Biosens Bioelectron; 2022 Aug; 209():114261. PubMed ID: 35429771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of drug-induced arrhythmic risk using limit cycle and autocorrelation analysis of human iPSC-cardiomyocyte contractility.
    Kirby RJ; Qi F; Phatak S; Smith LH; Malany S
    Toxicol Appl Pharmacol; 2016 Aug; 305():250-258. PubMed ID: 27343406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes.
    Doherty KR; Wappel RL; Talbert DR; Trusk PB; Moran DM; Kramer JW; Brown AM; Shell SA; Bacus S
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):245-55. PubMed ID: 23707608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms.
    Pang L; Sager P; Yang X; Shi H; Sannajust F; Brock M; Wu JC; Abi-Gerges N; Lyn-Cook B; Berridge BR; Stockbridge N
    Circ Res; 2019 Oct; 125(9):855-867. PubMed ID: 31600125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comprehensive in vitro cardiac safety assessment using human stem cell technology: Overview of CSAHi HEART initiative.
    Takasuna K; Asakura K; Araki S; Ando H; Kazusa K; Kitaguchi T; Kunimatsu T; Suzuki S; Miyamoto N
    J Pharmacol Toxicol Methods; 2017; 83():42-54. PubMed ID: 27646297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thymoquinone reduces mitochondrial damage and death of cardiomyocytes induced by clozapine.
    Hafez AA; Jamali Z; Khezri S; Salimi A
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Aug; 394(8):1675-1684. PubMed ID: 33937934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity.
    Sirenko O; Cromwell EF; Crittenden C; Wignall JA; Wright FA; Rusyn I
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):500-7. PubMed ID: 24095675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonclinical Safety and Toxicology.
    Stark C; Steger-Hartmann T
    Handb Exp Pharmacol; 2016; 232():261-83. PubMed ID: 26489827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems.
    Magdy T; Schuldt AJT; Wu JC; Bernstein D; Burridge PW
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():83-103. PubMed ID: 28992430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.
    Denning C; Borgdorff V; Crutchley J; Firth KS; George V; Kalra S; Kondrashov A; Hoang MD; Mosqueira D; Patel A; Prodanov L; Rajamohan D; Skarnes WC; Smith JG; Young LE
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1728-48. PubMed ID: 26524115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes.
    Nadanaciva S; Aleo MD; Strock CJ; Stedman DB; Wang H; Will Y
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):272-80. PubMed ID: 23811329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes.
    Zhao Q; Wang X; Wang S; Song Z; Wang J; Ma J
    Stem Cell Res Ther; 2017 Mar; 8(1):54. PubMed ID: 28279214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stabilization of Mitochondrial Function by Ellagic Acid Prevents Celecoxib-induced Toxicity in Rat Cardiomyocytes and Isolated Mitochondria.
    Atashbar S; Sabzalipour T; Salimi A
    Drug Res (Stuttg); 2021 Apr; 71(4):219-227. PubMed ID: 33276407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes.
    Guo L; Abrams RM; Babiarz JE; Cohen JD; Kameoka S; Sanders MJ; Chiao E; Kolaja KL
    Toxicol Sci; 2011 Sep; 123(1):281-9. PubMed ID: 21693436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.
    Gwathmey JK; Tsaioun K; Hajjar RJ
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):647-60. PubMed ID: 19442031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reducing attrition in drug development: smart loading preclinical safety assessment.
    Roberts RA; Kavanagh SL; Mellor HR; Pollard CE; Robinson S; Platz SJ
    Drug Discov Today; 2014 Mar; 19(3):341-7. PubMed ID: 24269835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic cardiotoxicity assessment of BMS-986094, a guanosine nucleotide analogue, using human iPS cell-derived cardiomyocytes.
    Yanagida S; Satsuka A; Hayashi S; Ono A; Kanda Y
    J Toxicol Sci; 2021; 46(8):359-369. PubMed ID: 34334557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-induced mitochondrial dysfunction and cardiotoxicity.
    Varga ZV; Ferdinandy P; Liaudet L; Pacher P
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1453-67. PubMed ID: 26386112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Silica nanoparticles induce cardiotoxicity interfering with energetic status and Ca
    Guerrero-Beltrán CE; Bernal-Ramírez J; Lozano O; Oropeza-Almazán Y; Castillo EC; Garza JR; García N; Vela J; García-García A; Ortega E; Torre-Amione G; Ornelas-Soto N; García-Rivas G
    Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H645-H661. PubMed ID: 28130337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.